A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Core Scientific, Inc./tx
CORZ
$7.5B
Mkt Cap
$22.75
-5.05%
Core Scientific, Inc./tx (CORZ) has a 5-year average return on invested capital (ROIC) of -9.9%. This is below average and may indicate limited pricing power.
Core Scientific, Inc./tx (CORZ) has a market capitalization of $7.5B. It is classified as a mid-cap stock.
Core Scientific, Inc./tx (CORZ) does not currently pay a regular dividend.
Core Scientific, Inc./tx (CORZ) operates in the Finance Services industry, within the Financials sector.
Core Scientific, Inc./tx (CORZ) reported annual revenue of $319 million in its most recent fiscal year, based on SEC EDGAR filings.
Core Scientific, Inc./tx (CORZ) has a net profit margin of -90.5%. The company is currently unprofitable.
Core Scientific, Inc./tx (CORZ) generated $-451 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Core Scientific, Inc. (“we,” “us,” “our,” the “Company,” “Core Scientific,” or “Core”) designs, builds and operates large-scale, purpose-built data centers that support high-density colocation services and digital asset mining for both our own account and to a lesser extent, third-party customers. Our data centers are optimized for power-intensive, mission-critical computing workloads, with a focus on artificial intelligence (“AI”) and other high-performance computing (“HPC”) applications. As of December 31, 2025, we owned or leased ten data centers across seven U.S. states, representing approximately 1.4 gigawatts (“GW”) of gross utility power capacity, or approximately 920 megawatts (“MW”) of total leasable customer power capacity. A portion of these facilities were in operation as of December 31, 2025, with the remainder under construction or in various stages of development.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 319M | 319M | - | 502M | - | 544M |
| Net Income | -289M | -289M | -1.4B | -246M | -2.1B | 47M |
| EPS | $-0.88 | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.20 |
| Free Cash Flow | -451M | -451M | -52M | 49M | -179M | -57M |
| ROIC | -8.3% | -8.3% | -7.6% | -27.3% | -206.3% | 3.4% |
| Gross Margin | 11.9% | 11.9% | - | 24.6% | - | 43.9% |
| Debt/Equity | 0.00 | -1.10 | -1.14 | -0.13 | -0.00 | 0.12 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -246M | -246M | -142M | -246M | -2.1B | 131M |
| Operating Margin | -77.0% | -77.0% | - | -48.9% | - | 24.2% |
| ROE | 0.0% | - | - | - | - | 3.5% |
| Shares Outstanding | 328M | 328M | 295M | 379M | 341M | 237M |
| Metric | ||||||
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 544M | N/A | 502M | N/A | 319M | 319M |
| Gross Margin | 43.9% | N/A | 24.6% | N/A | 11.9% | 11.9% |
| R&D | 7.7M | 27M | 7.2M | 12M | N/A | N/A |
| SG&A | 60M | 253M | 108M | 114M | 159M | 159M |
| EBIT | 131M | -2.1B | -246M | -142M | -246M | -246M |
| Op. Margin | 24.2% | N/A | -48.9% | N/A | -77.0% | -77.0% |
| Net Income | 47M | -2.1B | -246M | -1.4B | -289M | -289M |
| Net Margin | 8.7% | N/A | -49.1% | N/A | -90.5% | -90.5% |
| Non-Recurring | -118K | 563M | 1.0B | 1.0B | 1.7M | 1.7M |
| Returns on Capital | ||||||
| ROIC | 3.4% | N/M | -27.3% | -7.6% | -8.3% | -8.3% |
| ROE | 3.5% | N/A | N/A | N/A | N/A | 0.0% |
| ROA | 1.9% | -265.7% | -34.6% | -97.4% | -15.1% | -12.3% |
| Cash Flow | ||||||
| Op. Cash Flow | -57M | 205M | 65M | 43M | 278M | 278M |
| Free Cash Flow | -57M | -179M | 49M | -52M | -451M | -451M |
| Owner Earnings | -129M | -203M | -90M | -122M | 111M | 111M |
| CapEx | 0 | 384M | 16M | 95M | 729M | 729M |
| Maint. CapEx | 33M | 225M | 96M | 113M | 69M | 69M |
| Growth CapEx | N/A | 159M | 0 | 0 | 660M | 660M |
| D&A | 33M | 225M | 96M | 113M | 69M | 69M |
| CapEx/OCF | N/A | N/A | N/A | 221.4% | 262.0% | 262.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 39M | 183M | 59M | 52M | 98M | 98M |
| Debt Repayment | 49M | 113M | 41M | 305M | 8.6M | 8.6M |
| Balance Sheet | ||||||
| Net Debt | -69M | -32M | -26M | -597M | 438M | 749M |
| Cash & Equiv. | 118M | 16M | 50M | 836M | 311M | 311M |
| Long-Term Debt | 62M | 0 | 36M | 1.1B | 1.1B | 1.1B |
| Debt/Equity | 0.12 | 0.00 | -0.13 | -1.14 | -1.10 | 0.00 |
| Interest Coverage | 16.4 | -7350.4 | -12.3 | -291.7 | -127.1 | -127.1 |
| Equity | 1.3B | -409M | -597M | -943M | -963M | -963M |
| Total Assets | 2.4B | 808M | 712M | 1.5B | 2.3B | 2.3B |
| Total Liabilities | 1.1B | 1.2B | 1.3B | 2.4B | 3.3B | 3.3B |
| Intangibles | 8.2M | 1.7M | N/A | N/A | N/A | N/A |
| Retained Earnings | -27M | -2.2B | -2.4B | -3.9B | -4.1B | -4.1B |
| Working Capital | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Per Share Data | ||||||
| EPS | 0.20 | -6.30 | -0.65 | -4.87 | -0.88 | -0.88 |
| Owner EPS | -0.55 | -0.60 | -0.24 | -0.41 | 0.34 | 0.34 |
| Book Value | 5.67 | -1.20 | -1.57 | -3.19 | -2.94 | -2.94 |
| Cash Flow/Share | -0.24 | 0.60 | 0.17 | 0.15 | 0.85 | -0.67 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 236.6M | 340.7M | 379.2M | 295.3M | 328.0M | 328.0M |
| Valuation | ||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | -25.9 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | 13.8 | 23.4 |
| FCF Yield | N/A | N/A | N/A | -1.3% | -9.0% | -6.0% |
| Market Cap | N/A | N/A | N/A | 4.1B | 5.0B | 7.5B |
| Avg. Price | N/A | N/A | N/A | 8.77 | 13.42 | 22.75 |
| Year-End Price | N/A | N/A | N/A | 14.05 | 15.29 | 22.75 |
Core Scientific, Inc./tx passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 26.8%.
Core Scientific, Inc./tx (CORZ) reported earnings per share (EPS) of $-0.88 in its most recent fiscal year.
Core Scientific, Inc./tx (CORZ) has a 5-year average gross margin of 26.8%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 5 years of financial data for Core Scientific, Inc./tx (CORZ), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Core Scientific, Inc./tx (CORZ) has a book value per share of $-2.94, based on its most recent annual SEC filing.
No recent press releases.